BWP
NSPR icon

Baldwin Wealth Partners’s InspireMD NSPR Stock Holding History

Baldwin Wealth Partners’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,851
Closed -$7.64K – 755
2024
Q3 		$7.64K Buy
+2,851
New +$7.78K ﹤0.01% 833

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AF
Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return

Baldwin Wealth Partners's NSPR Position: Q4 2024 in Review

Baldwin Wealth Partners sold out of InspireMD (NSPR) in Q4 2024, closing a stake of 2,851 shares — an estimated $7.64K sold.

Baldwin Wealth Partners first reported a position in NSPR in Q3 2024 and held it in 1 quarter. The position peaked at $7.64K in Q3 2024. 30 funds tracked by Wall St. Rank hold NSPR as of Q4 2024.

  • Baldwin Wealth Partners reported no remaining InspireMD position as of Q4 2024 after selling out during the quarter.
  • Baldwin Wealth Partners sold 2,851 InspireMD shares in Q4 2024, an estimated $7.64K.
  • Baldwin Wealth Partners first reported a position in InspireMD in Q3 2024 and held it in 1 quarter.
  • Baldwin Wealth Partners's InspireMD position peaked at $7.64K in Q3 2024.
  • 30 funds tracked by Wall St. Rank held InspireMD as of Q4 2024.

Based on Baldwin Wealth Partners's 13F filing for Q4 2024, filed 22 Jan 2025.